The Allen Institute for AI (Ai2) and Providence Swedish revealed AutoDiscovery, an AI hypothesis engine that uncovered confirmed immune activity in historically 'immune-cold' lobular breast cancer.

Key Takeaways

  • Demonstrates autonomous hypothesis generation and cross-dataset validation verified by clinical pathologists;
  • Discovers active immune signals in lobular cancer to open new potential immunotherapy treatment pathways;
  • Open research methodology and tooling released by Ai2 to accelerate scientific discovery in oncology.